BackAdaptimmune Therapeutics Plc Overview
Adaptimmune Therapeutics Plc - ADR

Adaptimmune Therapeutics Plc Target Price

Analysts' 12-month price predictions for ADAP.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.05

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-07-30H.C. WainwrightArthur He$48147.4% upsideOpen
2024-05-30ScotiabankGeorge Farmer$3.156394.8% upsideOpen
2024-05-17Mizuho SecuritiesGraig Suvannavejh$36085.6% upsideOpen
2024-05-16BarclaysPeter Lawson$11961.9% upsideOpen
2022-11-14Wells Fargo$36085.6% upsideOpen